Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Genes are the fundamental physical and functional units of heredity, consisting of specific sequences of DNA that provide the instructions for synthesizing functional molecules, such as proteins or various types of RNA (National Human Genome Research Institute, 2024). In the context of pharmacology and drug discovery, the term 'Genes' is considered too broad and non-specific to be classified as a singular therapeutic target. While medical interventions like gene therapy or CRISPR-based editing target individual, specific genes to correct mutations, the collective term encompasses the entire genome and does not describe a distinct druggable entity like a receptor or enzyme (National Institutes of Health, 2023). Most traditional drugs interact with the protein products of genes rather than the DNA sequences themselves. Because this entry refers to a general biological category rather than a specific, identifiable molecular target, it is flagged as an incorrect or overly general term for drug-target mapping purposes (UniProt, 2024).
Not applicable as 'Genes' is a broad biological category rather than a specific molecular target for drug binding.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Genes.